BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
35.68
+1.51 (4.42%)
At close: May 12, 2025, 4:00 PM
35.01
-0.67 (-1.88%)
After-hours: May 12, 2025, 7:59 PM EDT

BridgeBio Pharma Statistics

Total Valuation

BBIO has a market cap or net worth of $6.77 billion. The enterprise value is $8.09 billion.

Market Cap 6.77B
Enterprise Value 8.09B

Important Dates

The last earnings date was Tuesday, April 29, 2025, after market close.

Earnings Date Apr 29, 2025
Ex-Dividend Date n/a

Share Statistics

BBIO has 189.88 million shares outstanding. The number of shares has increased by 11.59% in one year.

Current Share Class 189.88M
Shares Outstanding 189.88M
Shares Change (YoY) +11.59%
Shares Change (QoQ) +0.37%
Owned by Insiders (%) 4.82%
Owned by Institutions (%) 69.27%
Float 139.41M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 52.91
Forward PS 24.77
PB Ratio -4.13
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 63.51
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.57

Current Ratio 4.57
Quick Ratio 4.31
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -5.67

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -48.27%
Return on Invested Capital (ROIC) -91.66%
Return on Capital Employed (ROCE) -91.62%
Revenue Per Employee $174,541
Profits Per Employee -$915,025
Employee Count 730
Asset Turnover 0.15
Inventory Turnover n/a

Taxes

In the past 12 months, BBIO has paid $1.15 million in taxes.

Income Tax 1.15M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +22.61% in the last 52 weeks. The beta is 1.15, so BBIO's price volatility has been higher than the market average.

Beta (5Y) 1.15
52-Week Price Change +22.61%
50-Day Moving Average 34.38
200-Day Moving Average 29.57
Relative Strength Index (RSI) 51.21
Average Volume (20 Days) 3,183,254

Short Selling Information

The latest short interest is 22.18 million, so 11.68% of the outstanding shares have been sold short.

Short Interest 22.18M
Short Previous Month 22.31M
Short % of Shares Out 11.68%
Short % of Float 15.91%
Short Ratio (days to cover) 7.15

Income Statement

In the last 12 months, BBIO had revenue of $127.42 million and -$667.97 million in losses. Loss per share was -$3.54.

Revenue 127.42M
Gross Profit 121.50M
Operating Income -668.41M
Pretax Income -453.82M
Net Income -667.97M
EBITDA -662.65M
EBIT -668.41M
Loss Per Share -$3.54
Full Income Statement

Balance Sheet

The company has $540.60 million in cash and $1.86 billion in debt, giving a net cash position of -$1.32 billion or -$6.94 per share.

Cash & Cash Equivalents 540.60M
Total Debt 1.86B
Net Cash -1.32B
Net Cash Per Share -$6.94
Equity (Book Value) -1.64B
Book Value Per Share -8.68
Working Capital 543.07M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$500.42 million and capital expenditures -$238,000, giving a free cash flow of -$500.66 million.

Operating Cash Flow -500.42M
Capital Expenditures -238,000
Free Cash Flow -500.66M
FCF Per Share -$2.64
Full Cash Flow Statement

Margins

Gross Margin 95.35%
Operating Margin -524.60%
Pretax Margin -530.27%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

BBIO does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -11.59%
Shareholder Yield -11.59%
Earnings Yield -9.86%
FCF Yield -7.39%
Dividend Details

Analyst Forecast

The average price target for BBIO is $57.09, which is 60.01% higher than the current price. The consensus rating is "Strong Buy".

Price Target $57.09
Price Target Difference 60.01%
Analyst Consensus Strong Buy
Analyst Count 12
Revenue Growth Forecast (5Y) 59.46%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

BBIO has an Altman Z-Score of -5.54 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -5.54
Piotroski F-Score 1